TMC114-C214: Trial of TMC114 Administered With Low Dose Ritonavir (RTV) in HIV-1 Infected Treatment Experienced Patients
Clinical trial NCT00110877 · COMPLETED
Trial details
- NCT number
- NCT00110877
- Sponsor
- Tibotec Pharmaceuticals, Ireland
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-04-01
- Primary completion
- 2007-01-01
- Enrollment
- 604
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.